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Cardiac Response to Acute Stretch: 
Literature Review and a New Diastolic Paradigm 
Abstract 1 
 2 
Myocardial stretch, as result of acute hemodynamic overload, is one of the most frequent 3 
challenges to the heart and the ability of the heart to intrinsically adapt to it is essential to 4 
prevent circulatory congestion. In a literature review, the historical background, the 5 
currently known mechanisms, as well as the gaps in the understanding of this 6 
physiological response are highlighted. The systolic adaptation to stretch is well known 7 
for over 100 years, being dependent on an immediate increase in contractility – known as 8 
the Frank-Starling mechanism – and a further progressive potentiation – the slow force 9 
response. On the other hand, its diastolic counterpart remains largely unstudied. cGMP-10 
related pathways are activated upon stretch and its downstream effector PKG is known 11 
to phosphorylate titin, a major determinant of myocardial stiffness. Therefore, we aimed 12 
to investigate the role of these pathways on decreasing stiffness during acute loading via 13 
titin phosphorylation in healthy and diseased hearts. Left ventricle (LV) of intact rat 14 
hearts, strips dissected from the LV or right atrium of cardiac surgery patients and rabbit 15 
papillary muscles were acutely stretched. In cardiac surgery patients, LV pressure and 16 
volume were recorded before and 15 minutes after volume overload (VO). Effect of VO 17 
was also assessed in sham and TAC rats. After an immediate increase in response to 18 
stretch/VO, diastolic pressure and passive tension significantly decreased (≈30-40%) over 19 
the subsequent 15 min in all animal species and experimental preparations. This effect 20 
was significantly blunted by PKG inhibition and combined natriuretic peptide receptor 21 
inhibition and NO scavenging and was not observed in TAC hearts. Stretching skinned 22 
cardiomyocytes did not decrease passive tension but it was ≈60% lower in those extracted 23 
from stretched hearts, in which it increased with protein phosphatase but not PKG 24 
incubation. Titin phosphorylation increased markedly after acute myocardial stretch in 25 
human and rabbit myocardium. Hypophosphorylation and blunted response to VO was 26 
measured in TAC myocardium. These results point to a novel mechanism of diastolic 27 
adaptation to acute overload associated with increased myocardial compliance that is 28 
abolished in the hypertrophic heart. Decreased stiffness is associated with titin 29 
phosphorylation, in which PKG plays a central role. 30 
 31 
Keywords: cardiac function, myocardial stretch, neurohumoral adaptation, titin, 32 
diastole, heart failure, frank-starling mechanism, slow force response.  33 
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PART ONE: LITERATURE REVIEW 34 
 35 
Introduction 36 
 37 
The heart has a central role in the maintenance of cardiovascular homeostasis, which 38 
requires the ability to continuously adapt its function to different hemodynamic 39 
conditions.  40 
 41 
One of the most frequent challenges to myocardium is acute stretch, as result of acute 42 
hemodynamic overload. Acute myocardial stretch can be observed in various 43 
physiological and pathophysiological conditions (e.g. exercise, myocardial ischemia, 44 
hypertensive crises, valvular diseases and heart failure). For example, at the start of 45 
aerobic exercise (figure 1), the pumping action of skeletal muscle contraction increases 46 
the venous return, leading to cardiac chamber dilation and acute myocardial stretch 47 
(Nobrega et al., 1995). This increase in end-diastolic volume leads to an increase in end 48 
diastolic pressure that, in the absence of adequate response, would lead to pulmonary and 49 
systemic congestion. 50 
 51 
Being such a common challenge, one can expect the heart to have adequate intrinsic 52 
physiologic mechanisms to respond to this stimulus. The adequate physiological response 53 
to the acute increase in end-diastolic pressure must include: activation of stretch sensing 54 
molecules (the sensing organ), intermediary mechanisms (afferent, integrator and efferent 55 
pathways) and effector mechanisms that would ultimately allow the heart to reduce its 56 
increased end-diastolic pressure (figure 1). This could, in theory, be achieved by two 57 
different mechanisms:  58 
- A systolic adaptation: an increase in contractility, leading to an increased 59 
ejection volume and, consequently, a decreased end diastolic volume. 60 
- A diastolic adaptation: an increase in cardiac compliance, which would allow 61 
accommodating more blood at inferior end diastolic pressures. 62 
Both adaptations would increase cardiac output, which would also be appropriate to offset 63 
the increase in venous return.  64 
 65 
The first described mechanism of cardiac adaptation to an acute hemodynamic overload 66 
has been known for about a century (Katz, 2002). An increase in either venous return or 67 
aortic resistance leads to an increased end-diastolic volume and to an immediate increase 68 
in contractility and stroke volume. This response is presently known as Frank-Starling 69 
Mechanism (FSM) due to the contributes of Ernest H. Starling and Otto Frank to its 70 
description and is mainly attributed to enhanced myofilamental responsiveness to Ca2+, a 71 
phenomenon highly dependent on the tension developed by titin (Patterson and Starling, 72 
1914;Frank, 1959;Castro-Ferreira et al., 2011). Given its relevance for the cardiovascular 73 
homeostasis it is also known as the “law of the heart”. 74 
 75 
In 1912, von Anrep described that, after the initial change in muscle length and 76 
contractility induced by clamping the heart outflow, it is observed a progressive and time-77 
dependent increase in force development that goes beyond the force immediately 78 
achieved after stretch and is responsible for the return of end-diastolic volume back to its 79 
original value (von Anrep, 1912). This second progressive increase in force development, 80 
was demonstrated in vitro by Parmley and Chuck in 1973, being since then synonymously 81 
called slow force response (SFR) (Parmley and Chuck, 1973). 82 
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 83 
Both mechanisms highlight a highly effective systolic adaptation to an acute 84 
hemodynamic overload. A diastolic adaptation per se, although theoretically appropriate 85 
to the underlying challenge, remains largely unknown. 86 
 87 
In this paper, about 100 years after the initial publish of E. Starling about the relevance 88 
of stretch to heart function, we intend to review the great progress in understanding of the 89 
myocardial adaptation to acute stretch, as well as highlight the gaps in the understanding 90 
of this mechanism. 91 
 92 
Myocardial mechanosensing 93 
 94 
Mechanosensors are structures capable of perceiving mechanical signals and activating 95 
pathways that allow transduction of the signal into biochemical responses. The external 96 
forces exerted on the myocardium are transmitted through the sarcolemma (and 97 
associated adhesion structures: intercalated disks and costameres), cardiomyocyte 98 
cytoskeleton and sarcomeric proteins. Concurrently, the sarcomeres generate forces that 99 
propagate in the opposite direction. Several mechanosensor molecules in this mechanical 100 
chain have been identified, being the best characterized ones located in Z line, titin 101 
molecule, sarcolemma, intercalated disks and costameres. 102 
 103 
Recent reviews (Takahashi et al., 2013;Buyandelger et al., 2014;Lyon et al., 2015) 104 
addressed cardiac mechanotransduction in detail, particularly its relation to remodeling 105 
and chronic adaptation. The precise role of mechanosensors in the acute response to 106 
stretch is still mostly unknown, as few studies have directly addressed this issue. 107 
Therefore, in this topic, we intend to emphasize the great diversity of mechanosensors in 108 
the heart and highlight cellular components that, given their structure, mechanism of 109 
action and activated signaling pathways, may potentially contribute to the response to 110 
acute stretch (figure 2). 111 
 112 
The Z line divides two adjacent sarcomeres and is traditionally regarded as an essential 113 
element to the normal structural arrangement of the sarcomeres. However, its position 114 
confers to the Z disk the distinct ability to sense the muscular tension, during either the 115 
diastolic or the systolic period (Hoshijima, 2006). The Z line is composed not only of 116 
overlapping actin filaments of adjacent sarcomeres tightly linked by α-actinin, but also of 117 
numerous proteins bearing diverse signaling functions (Luther, 2009). Many of these 118 
proteins may be relevant for response to acute stretch, including: Protein Kinase C (PKC) 119 
ε (Robia et al., 2005), PKCδ (Disatnik et al., 1994), calcineurin (Frey et al., 2000) and 120 
phosphodiesterase 5 (Senzaki et al., 2001). 121 
 122 
Titin is a giant protein that spans the sarcomere from the Z-line to the M-line. Its 123 
molecular structure makes this protein work as a bidirectional spring that determines the 124 
myocardial passive tension (PT) at different lengths (Castro-Ferreira et al., 2011). In 125 
addition to its structural and elastic function, titin also functions as a biomechanical sensor 126 
sensing myocardial tension as well as the sarcomeric length. The central role of titin in 127 
mechanosensing and its ability to trigger downstream signaling cascades is related to its 128 
interactions with numerous structural proteins and signaling proteins at its M-band, Z 129 
line, N2B, N2A and PEVK-domains (Linke and Kruger, 2010). Titin also features a 130 
kinase domain near the carboxyl-terminal (located in the M-line region) (Mayans et al., 131 
1998), which may phosphorylate target proteins at specific sites, according to myocardial 132 
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stretching (Puchner and Gaub, 2010). Moreover, titin presents various phosphorylation 133 
sites of its own at PEVK and N2B domains (Krüger and Linke, 2011), whose 134 
phosphorylation alters PT conferred by titin, either decreasing or increasing it (Ahmed 135 
and Lindsey, 2009). This mechanism confers titin a special role in mechanosensing, 136 
allowing it to simultaneous function as a mechanosensor and a molecular target. 137 
Therefore, it is tempting to hypothesize that upon an increase in acute PT, titin is capable 138 
of initiating a compensatory mechanism that, ultimately, would lead to decreased titin’s 139 
PT with consequent normalization of sarcomeric PT. It is important to highlight that, as 140 
the main determinant of myocardial PT, modifications of titin phosphorylation status will 141 
also modify the activity of remaining mechanosensors. 142 
 143 
The sarcolemma separates the intracellular and extracellular environments. This structure 144 
is teeming with different receptors subject to activation by extracellular mediators that set 145 
different intracellular pathways in motion. However, several sarcolemma proteins can 146 
also be activated by cellular stretch, initiating intracellular pathways without binding of 147 
extracellular mediators (Storch et al., 2012). Stretch activated channels (SACs) are a 148 
paradigmatic example of this type of activation in cytoplasmic membranes (Reed et al., 149 
2014). In cardiomyocytes, upon stretch, SACs are permeable to of sodium, potassium and 150 
calcium, thereby modulating electrical and mechanical proprieties of myocardium. The 151 
AT1 receptor, a G protein-coupled receptor, can also be directly activated by stretch 152 
without the involvement of angiotensin II (Zou et al., 2004). This agonist-independent 153 
activation may have a determinant role in the myocardial response to acute stretch. The 154 
blockade of this receptor has been associated with a significantly blunted SFR (Heidkamp 155 
et al., 2003). 156 
 157 
The interaction of cardiomyocytes with neighboring cells (at intercalated discs) and with 158 
the extracellular matrix (at costameres) is key to the maintenance of the structural 159 
integrity of the myocardium, as well as the transmission of forces between cells (Kresh 160 
and Chopra, 2011). Beyond this function, some components of intercalated discs and 161 
costameres are known to be involved in mechanosensing (Samarel, 2005). At the level of 162 
intercalated discs, the main structures capable of contributing to mechanosensing are 163 
fascia adherens junctions (constituted by N-cadherin and associated multi-molecular 164 
complex anchoring cytoskeletal actin) and desmosomes (composed of the cell adhesion 165 
proteins desmoglein and desmocollin and associated proteins internally linked to the 166 
intermediate filament desmin) (Sheikh et al., 2009). Both structures are known to 167 
contribute to long-term cytoskeletal adaptive responses to different pathophysiological 168 
forces (Lyon et al., 2015), but their importance in the acute response remains unknown. 169 
Regarding costameres, one important component contributing to mechanosensing are 170 
integrins. These heterodimeric transmembrane receptors located at costameres contribute 171 
to the connection between extracellular matrix and the intracellular cytoskeleton, and 172 
therefore to the transmission of mechanical signals to the cytoskeleton (Israeli-Rosenberg 173 
et al., 2014). One well-known mediator of integrin mechanosensing is focal adhesion 174 
kinase (FAK) (Domingos et al., 2002b). The signaling resultant of FAK activation is 175 
proportional to the magnitude and duration of mechanical stretch (Katz et al., 2002). FAK 176 
activity is also related to various signaling pathways potentially relevant to the acute 177 
response to stretch, including ERK1/2 (Domingos et al., 2002a) and PKC ε (Heidkamp et 178 
al., 2003). Another mediator that may be particularly important for the acute transduction 179 
of integrin signaling is integrin-linked kinase (ILK). ILK appears to mediate 180 
cardiomyocyte force transduction via regulation of the SERCA2A activity and 181 
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phosphorylation of phospholamban (Traister et al., 2014), which may contribute both to 182 
the systolic and diastolic adaptation to acute stretch. 183 
 184 
Although several potential mechanosensing molecules have been identified, the 185 
connection between these molecules and stretch activated pathways remains elusive. This 186 
lack of knowledge is even more pronounced when it comes to the acute activation of these 187 
pathways by these molecules. 188 
 189 
Furthermore, the interrelation between those sensors is complex, and the spread 190 
synergism and crosstalk between the pathways activated downstream of those sensors 191 
lead to a broad activation of signaling pathways that acutely modulate heart function, 192 
which is probably crucial to the ability of myocardium to adapt to acute hemodynamic 193 
overload. 194 
 195 
Calcium-dependent Pathways 196 
 197 
Calcium (Ca2+) is the central player in the biphasic systolic adaptation to myocardial 198 
stretch. Besides its involvement in the FSM, an increase in the intracellular concentration 199 
of Ca2+ underlies the SFR (figure 3).  200 
 201 
Angiotensin-II (ANG-II) and endothelin (ET) are two peptide hormones (8 and 21 amino 202 
acids long, respectively) that share some interesting features. Via binding to receptors 203 
coupled to protein Gq and subsequent release of Ca2+ from intracellular stores and 204 
activation of protein kinase C (PKC), they increase cardiac inotropism and have a pressor 205 
effect on blood vessels (figure 3). Though they normally play a role in the physiological 206 
regulation of blood pressure by altering salt and water balance and vasomotor tone 207 
(especially in renal vessels), they have been implicated in the pathophysiology of 208 
pulmonary and systemic hypertension and heart failure (Brunner et al., 2006;Mehta and 209 
Griendling, 2007). 210 
 211 
More recently, the study of the role of local angiotensin and endothelin systems in cardiac 212 
function and pathophysiology has been prolific. These have been implicated in the 213 
process of cardiac remodelling that takes place as a result of neurohumoral activation in 214 
congestive heart failure (Brunner et al., 2006;De Mello and Frohlich, 2011) but they also 215 
seem to be central in the modulation of the acute myocardial response to stretch, 216 
contributing to the genesis of the FSM and the development of the SFR (Cingolani et al., 217 
2011). In fact, Sadoshima et al. first demonstrated that cultured neonatal cardiomyocytes 218 
directly released ANG-II from intracellular vesicles in response to an acute 10 or 30 219 
minute stretch, generating a concentration of around 1 nM in the culture medium 220 
(Sadoshima et al., 1993). The positive inotropic response to acute stretch is similar to that 221 
elicited by addition of exogenous ANG-II in amounts of the same order of magnitude and 222 
can be blocked by inhibition of AT1 but not AT2 receptors (Caldiz et al., 2007). However, 223 
this effect seems to depend on downstream release of ET, as inhibition of ET receptors, 224 
as well as the ET converting enzyme, ablated both the SFR and the increase in 225 
contractility that accompanies ANG-II administration but AT1 receptor blocking did not 226 
prevent the positive inotropic effect of exogenous ET (Perez et al., 2003). Accordingly, 227 
Anderson et al. reported that ET synthesis in myocytes increases following myocardial 228 
stretch (Anderson et al., 2004). 229 
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Taking these results into account, along with their own, Cingolani’s group has since 230 
described a complex autocrine/paracrine pathway involving changes in membrane ion 231 
currents mediated by ANG-II and ET that sheds some light on the role played by these 232 
molecules in the response to myocardial stretch (Cingolani et al., 2011). They propose 233 
that the initial step in generating the SFR is an ANG-II dependent release of endogenous 234 
ET by poorly described mechanisms that may involve activation of the mineralocorticoid 235 
receptor by aldosterone or another non-identified ligand. 236 
 237 
Although all three endothelin isoforms have equal positive inotropic potency when 238 
exogenously administered, ET-3 is the most likely to be responsible for SFR in a 239 
physiological setting (Ennis et al., 2005). The ET receptor then transactivates the 240 
epidermal growth factor receptor (EGFR) through various pathways. The best described 241 
one involves activation of matrix metalloproteinases and subsequent release of heparin-242 
binding epidermal growth factor (HBEGF), which binds to and activates EGFR. This 243 
supposedly triggers an intracellular signalling pathway leading to increased production 244 
and release of reactive oxygen species (ROS) by mitochondriae through opening of 245 
mitochondrial KATP channels (Anderson et al., 2004;Villa-Abrille et al., 2010). Redox-246 
sensitive kinases ERK1/2 and p90rsk therefore increase their activity in response to stretch 247 
and phosphorylate the regulatory domain of the sodium-proton exchanger 1 (NHE1), 248 
increasing its activity and cytoplasmic [Na+].  249 
 250 
This transporter has long been implicated in the development of the SFR and this is 251 
thought to occur through modulation of ion electrochemical gradients that the increased 252 
[Na+] provokes. In this setting, the sodium-calcium exchanger (NCX), which usually 253 
extrudes calcium, reverses direction of transport, increasing the amplitude of Ca2+ 254 
transients and, consequently, contractile force (figure 3).  255 
 256 
On the other hand, the increased Ca2+ transient, through favored actin-myosin interaction, 257 
could result in alarming levels of muscle stiffness. Thus, it is not surprising that other 258 
stretch activated mechanisms promote muscle relaxation by improving Ca2+ extrusion 259 
from cytosol after myocardial contraction. In fact, there is a well described acute increase 260 
in SERCA expression following hemodynamic overload (Kögler et al., 2006). Besides, 261 
Ca2+ load following stretch binds to the several Ca2+ binding proteins in the heart, with 262 
S100A1 being the most abundant member of the calcium-binding S100 protein family in 263 
myocardial tissue (Duarte-Costa et al., 2014). S100A1-Ca2+ complex frees the actin from 264 
titin, reducing the PT imposed by titin-actin interaction (Yamasaki et al., 2001). The 265 
relative importance of these mechanisms in the passive properties of the heart following 266 
stretch has not been studied in detail. 267 
 268 
The complex loop involving ANG-II and ET still has gaps to be filled and seemingly 269 
contradictory results exist in the literature. Our own results confirm the major role of AT1 270 
receptors and the NHE-1 and NCX transporters in the development of SFR and the 271 
positive inotropic effect of the external addition of ANG-II on myocardium in normal 272 
conditions, which subsequently blunts SFR, presumably by saturating the contractile 273 
reserve of the pathway in the absence of stretch. In addition, it points to a possible role of 274 
PKC in maintaining the SFR during the late phase of acute stretch (Neves et al., 2013). 275 
Interestingly, our group has also described the role of these peptides on the acute 276 
modulation of diastolic function through direct effects on both relaxation velocity and 277 
myocardial stiffness. Activation of ETA and AT1 receptors results in positive lusitropism 278 
and decreased stiffness, while ETB and AT2 receptors promote negative lusitropism. As 279 
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in its systolic counterpart, AT1 receptor activation seems upstream to endothelin release 280 
in the pathway that leads to faster myocardial relaxation, as this effect is dependent on 281 
ETA receptor activity and an intact endocardial endothelium (Bras-Silva and Leite-282 
Moreira, 2006;Castro-Chaves et al., 2006). Concurrently, decreasing stiffness depends on 283 
the activity of both NHE1 and PKC and on the integrity of the endocardial endothelium 284 
(Leite-Moreira et al., 2003;Bras-Silva and Leite-Moreira, 2006;Leite-Moreira et al., 285 
2006). 286 
 287 
Pathways involving Nitric Oxide and Cardiac Natriuretic Hormones 288 
 289 
Cardiac stretch stimulates both endothelial cells and cardiomyocytes to produce nitric 290 
oxide (NO) (Casadei and Sears, 2003). In endothelial cells, large amounts of NO are 291 
produced by the endothelial nitric oxide synthase (NOS), after which it rapidly diffuses 292 
to neighboring cardiomyocytes (figure 3). In the cardiomyocyte, NO is produced in 293 
relatively low levels by both endothelial NOS and neuronal NOS (nNOS) (Petroff et al., 294 
2001;Khan et al., 2003). 295 
 296 
As NO produced by endothelial cells diffuses through the cardiomyocyte, soluble 297 
guanylate cyclase present in the cytoplasm is activated, leading to an increase in cGMP 298 
concentration in the cytosolic compartment. The effect of cGMP is mediated through 299 
protein kinase G (PKG), which is able to phosphorylate troponin I (TnI), rendering a 300 
reduction of myofilamentary sensitivity to calcium, therefore increasing the rate of Ca2+ 301 
dissociation (Layland et al., 2005). NO produced by nNOS, which is located in the 302 
sarcoplasmic reticulum membrane, simultaneously modulates the diastolic properties of 303 
the heart through PKA-dependent phosphorylation of phospholamban (PLB) in a cGMP-304 
independent pathway (Zhang et al., 2008). The phosphorylation of PLB disinhibits the 305 
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which rapidly reuptakes free 306 
cytoplasmic Ca2+. Taken together, NO mediated pathways, both cGMP-dependent and –307 
independent, hasten myocardial relaxation (positive lusitropism), prolonging the diastolic 308 
time interval while reducing the PT of cardiomyocytes. These changes in myocardial 309 
properties are crucial for the heart to accommodate increasing preloads, without 310 
substantial changes in the intracardiac filling pressures (figure 3). 311 
 312 
Besides altering the diastolic properties of the heart, NO also modulates its contractility. 313 
NO-derived cGMP coexists in the cytoplasm with several members of the 314 
phosphodiesterase (PDE) family. Proteins of this family are metallophosphohydrolases 315 
that cleave cGMP and/or cAMP to 5’-GMP and 5’-AMP, inhibiting the activation of PKG 316 
and Protein Kinase A (PKA), respectively (Zaccolo and Movsesian, 2007). Therefore, 317 
although stretch induces an increase in the production of NO, the cytoplasmic 318 
concentration of NO-derived cGMP is kept relatively low due to continuous hydrolysis 319 
mediated by PDE5, located preferentially in Z-bands, in a cGMP-activated negative 320 
feedback mechanism. An important crosstalk between cGMP and cAMP pathways 321 
occurs, as low concentrations of cGMP inhibit PDE3, thus preventing the hydrolysis of 322 
cAMP (Francis et al., 2010). Accumulated cytoplasmic cAMP activates PKA, which is 323 
then responsible for the phosphorylation of several proteins involved in cardiac 324 
contraction (figure 3). These include the sarcolemmal voltage-gated L-Type Ca2+ 325 
channels, SR Ca2+ release channel (ryanodine receptor, RyR2), PLB, the phosphatase 1 326 
inhibitor, TnI and myosin binding protein C, all aiming to increase myocardial 327 
contractility (Fischmeister et al., 2006). Interestingly, a prolonged activation of RyR2 328 
could ultimately lead to SR Ca2+ depletion, and consequently to a paradoxal negative 329 
Cardiac response to acute stretch	
 8 
inotropism; however, activation of SERCA, as previously stated, is able to replenish the 330 
SR Ca2+ pool and maintain this cycle. RyR2 can also be opened via cyclic adenosine 331 
diphosphate ribose, which is produced by a PKG mediated phosphorylation of adenosine 332 
diphosphate ribosylcyclase (Willmott et al., 1996). NO can also exert an important effect 333 
on the systolic properties of the myocardium per se in a cGMP-independent pathway. NO 334 
produced by nNOS directly S-nitrosylates reactive thiol residues within RyR2, which also 335 
contributes to an increased Ca2+ release (Wang et al., 2010). Taken together, NO mediated 336 
pathways, both cGMP-dependent and -independent, enhance myocardial contractility 337 
(positive inotropism) in response to stretch, allowing the heart to pump more vigorously 338 
the increasing blood volume arriving after each heartbeat (figure 3). Accordingly, we 339 
recently demonstrated in rabbit papillary muscles that acute myocardial stretch in the 340 
presence of a PKG inhibitor leads to a significant attenuation of the SFR (Castro-Ferreira 341 
et al., 2014). 342 
 343 
Cardiac stretch also stimulates cardiomyocytes to release cardiac natriuretic hormones 344 
(CNH), namely atrial natriuretic peptide and brain natriuretic peptide. Both exert their 345 
cardiac effect by activating cell surface-associated particulate guanylate cyclase A, which 346 
in turn increases the concentration of cGMP in the subsarcolemmal compartment 347 
(Francis, 2010) (figure 3). However, in opposition to NO-derived cGMP, whose 348 
concentration is kept low through a PDE5 mediated negative feedback mechanism, CNH-349 
derived cGMP triggers a feed-forward mechanism that increases cGMP concentration 350 
even more (Castro et al., 2010). While this important difference is not reflected in the 351 
relaxation properties of the myocardium, as similarly to NO, CNH exert a positive 352 
lusitropic effect through phosphorylation of PLB and TnI, high levels of cGMP stimulate 353 
PDE2, reducing cAMP levels, which explains the absence of a positive inotropic effect 354 
following CNH release (Potter et al., 2006). 355 
 356 
Both NO and CNH can exert their effects through cGMP; however their physiological 357 
role may be quite different. The production/degradation of NO is finely tuned and occurs 358 
at a very high pace, meaning that NO must probably be related to adaptations to acute 359 
stretch on a beat-to-beat basis (e.g. in inspiration, changing from orthostatic to lying 360 
position). Contrastingly, and taking into account their diuretic effects in the kidney and 361 
longer half-life than NO, CNH could be more important in hypervolemic, hypertensive 362 
states, where stretch is prolonged in time, which explains the importance in relaxing the 363 
myocardium without increasing contractility, which would be deleterious. 364 
 365 
Effects of ischemia on the myocardial response to acute stretch 366 
 367 
Myocardial ischemia is a paradigmatic situation of acute hemodynamic overload in which 368 
abnormal myocardial loading activates a variety of cellular responses. During an ischemic 369 
event, several neurohumoral agents are released, which contribute to the overall 370 
physiologic process of cardiac adaptation to hemodynamic overload. Though significant 371 
advances in knowledge have been made in the last three decades regarding the processes 372 
involved in the pathophysiological consequences of ischemia per se, the cardiac response 373 
to stretch under those conditions is just taking its first steps. 374 
 375 
As previously stated, the myocardial response to stretch is a two-step adaptive response. 376 
The contractile response following acute stretch under ischemic conditions has been less 377 
studied. In a recent study carried out by our group, it was clearly demonstrated that this 378 
response is profoundly affected, as shown not only by a blunted FSM but also by the 379 
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abolishment of the SFR (Neves et al., 2013), thus supporting some previous indirect 380 
observations (Goto et al., 1988;Owen et al., 1993). In the human heart, after an occlusion 381 
of a coronary artery, pH falls within 15 seconds (Poole-Wilson, 1989), possibly 382 
contributing to the loss of contractility (Steenbergen et al., 1977;Patangay et al., 383 
2009;Decker et al., 2012) due to a reduced sensitivity of the myofilaments to calcium 384 
(Kihara et al., 1989;Salas et al., 2006), consequently leading to a diminished Ca2+ 385 
availability to bind to troponin C. Metabolic abnormalities should not be excluded, as 386 
they lead to insufficient energy supply to support cardiac work due to MgADP 387 
accumulation, which decreases the sliding velocity in the vicinity ATPase, slowing down 388 
the contraction cycle (Sata et al., 1996) and impairing the FSM (Robinson et al., 2002). 389 
These mechanisms are probably responsible for the observed ablation of the SFR in these 390 
conditions. A possible explanation for this was given recently by our group, 391 
demonstrating that this effect was AT1R-dependent and partially AT2R-dependent: 392 
blocking AT1R, under ischemic conditions, leads to a soft decline of contraction capacity 393 
in response to stretch (Neves et al., 2013). This effect may also be mediated by AT2R 394 
activation through bradykinin, PKC and cGMP (Jugdutt and Balghith, 2001). 395 
 396 
Little is known about the role of the PKC under ischemic conditions. As previously stated, 397 
PKC activity is more significant during the late phase of the SFR, preventing the 398 
development of a slow force decline. Also, under ischemic conditions, PKC was not 399 
capable of modifying contractile performance (Neves et al., 2013). This is consistent with 400 
its inability to alter the systolic adaptation during early phase of the response to stretch 401 
and does not exclude that its downstream mediators may be compromised in such 402 
conditions. However, PKC has several isoforms, some of them present within the same 403 
cell and activated by the same stimuli but showing different and, at times, opposite effects. 404 
For example, in ischemic heart disease, PKCδ induced decreased ATP generation 405 
(Inagaki et al., 2003), and therefore, insufficient energy supply may play a role. As such, 406 
it would be interesting to study how each one modulates the contractile response to stretch 407 
under ischemic conditions. 408 
 409 
Usually, in the setting of myocardial infarction, the PKG signaling pathway through NO 410 
and CNH is modulated pharmacologically by nitrates as NO donors. Also, administration 411 
of PDE5 inhibitors may be promising therapeutic targets (Kukreja, 2013). However, only 412 
recently the specific role of the PKG signaling pathway in ischemic conditions was 413 
shown. Intriguingly, activation of PKG pathway did not alter the SFR in ischemic 414 
conditions, while PDE5 inhibition significantly mitigated the contractile decline after 415 
stretch in ischemia (Castro-Ferreira et al., 2014). This can be explained by NO/cGMP-416 
independent cardioprotective effects (Elrod et al., 2007). However, the mechanisms 417 
responsible for the protective action of the sildenafil remain to be fully elucidated. 418 
 419 
Conclusion 420 
 421 
The myocardial response to acute stretch represents a fundamental adaptive capacity of 422 
the heart. Although this functional response to hemodynamic overload has been known 423 
for long time, the structures responsible for mechanosensing, as well as the pathways 424 
involved in the response, are still only partially clarified. The possibility of concomitant 425 
diastolic adaptation, although theoretically appropriate, has never been directly assessed.  426 
Despite the relevant knowledge accumulated on the cardiac response to acute 427 
hemodynamic overload, there is much that we still do not know. The quest for further 428 
understanding of the mechanosensing involved in this mechanism, the pathways 429 
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responsible for the response and the characterization of the diastolic adaptation may 430 
provide new insights, not only in its physiological importance, but also in the prevention 431 
and treatment of cardiovascular diseases, such as heart failure with reduced ejection 432 
fraction, heart failure with preserved ejection fraction, hypertensive crises or ischemic 433 
heart disease. 434 
 435 
PART TWO: A NEW DIASTOLIC PARADIGM 436 
 437 
Introduction 438 
Acute hemodynamic load variation represents a permanent challenge to the heart, 439 
warranting continuous adaptation to face such changes in cardiac demands. When preload 440 
increases, the resulting stretch of chamber walls triggers a classic biphasic response 441 
consisting of an immediate (FSM) and sustained (SFR) increase in contractility that is 442 
central to cardiac function (Patterson and Starling, 1914; Parmley and Chuck, 1973; 443 
Kockskamper et al., 2008). 444 
 445 
As stated in the previous section, this response is stimulated by factors produced or 446 
released at the onset of acute cardiac stretch, namely NO (Casadei and Sears, 2003) and 447 
B-type natriuretic peptide (BNP), both binding to receptors with guanylate cyclase 448 
domains and increasing sarcoplasmic cGMP levels (Potter et al., 2006; Francis, 2010). 449 
The systolic potentiation this second messenger produces is attributed, at these 450 
concentrations, to pathways including PKG-mediated phosphorylation of several key 451 
proteins regulating contraction, including PLB and TNI (Layland et al., 2005; Zhang et 452 
al., 2008; Castro-Ferreira et al., 2014), and also of adenosine diphosphate ribosylcyclase, 453 
increasing levels of cyclic ADP-ribose, which prolongs opening of sarcoplasmic 454 
reticulum Ca2+ channels (Willmott et al., 1996). 455 
 456 
Keeping up with this, the availability and viability of the pathways through which these 457 
molecules act appear dysregulated in heart failure (HF), of which decreased preload 458 
reserve is a hallmark and a central mechanism of symptomatic congestion (van Heerebeek 459 
et al., 2012). The associated oxidative stress scavenges NO into peroxynitrite species, 460 
which further impair cardiac function, and the plasmatic concentration of the active 461 
fragment of BNP is decreased, blunting natriuretic signalling despite increased levels of 462 
its inactive precursor, a commonly used biomarker of this disease (Zois et al., 2014). 463 
 464 
Interestingly, some of these factors acutely modulate diastolic function as well (Paulus et 465 
al., 1994; Shah and MacCarthy, 2000). An important target of PKG is titin, the giant 466 
sarcomeric protein accounting for most PT within the physiological range of sarcomere 467 
length (SL). By phosphorylating its N2B spring element, PKG shifts titin’s resting length 468 
downward, making it more distensible and reducing cardiomyocyte stiffness for the same 469 
SL (Kruger et al., 2009; Bishu et al., 2011). 470 
 471 
Therefore, there is reason to assume that similar mechanisms could play a role in a 472 
diastolic component in the adaptation to acute stretch, which remains unexplored. This 473 
hypothesis is further enlightened by evidence that low bioavailability of NO and cGMP, 474 
PKG hypoactivity (van Heerebeek et al., 2012; Franssen et al., 2015) and titin 475 
hypophosphorylation (Hamdani et al., 2013a) all importantly contribute to the 476 
pathophysiology of diastolic dysfunction observed in patients presenting with HF with 477 
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preserved ejection fraction (HFpEF). HFpEF represents more than 50% of HF cases, is 478 
associated with a poor prognosis and lacks therapeutic agents effective in reducing 479 
mortality and morbidity associated with it (Owan et al., 2006; Borlaug and Paulus, 2011). 480 
 481 
Given the grand implications of such a mechanism in cardiovascular physiology and 482 
potential impact in understanding the pathophysiology of HF, we aimed to describe a 483 
novel evolutionarily conserved mechanism of acute diastolic adaptation to hemodynamic 484 
overload in healthy and failing hearts and assess the contribution of PKG-related 485 
pathways and titin phosphorylation across several models, including the human heart. 486 
 487 
Material and Methods 488 
 489 
Isolated heart preparation: Wistar rat hearts (n=10) were perfused according to the 490 
Langendorff technique at constant pressure (Radnoti LLC, ADInstruments) and 491 
electrically paced. Pressure was monitored using a pressure tip catheter (Millar, Inc.) 492 
inside a fluid-filled balloon inserted into the left ventricle (LV) and volume was 493 
determined and controlled using a syringe pump (New Era Pump Systems). Balloon 494 
volume was set to a preload yielding a mean diastolic pressure of 3 mmHg and, after 495 
stabilization, inflated to a diastolic pressure of 10 mmHg for 15 minutes. After this period, 496 
the left ventricular free wall was rapidly dissected and frozen in liquid nitrogen for 497 
posterior analysis. 498 
 499 
Isolated muscle strip preparation: Force measurements were performed in papillary 500 
muscles dissected from the right ventricle of male New Zealand white rabbits and human 501 
atrial trabeculae (n=14) and human ventricular strips (n=10) strips from patients subject 502 
to cardiac surgery. The muscles were vertically mounted in an organ bath containing a 503 
modified Krebs-Ringer solution and the upper tendinous end was attached to an 504 
electromagnetic length–tension transducer (University of Antwerp, Belgium). The 505 
muscle was electrically stimulated to contract isometrically and the length at which active 506 
force development was maximal (Lmax) was determined. After stabilization at 92% Lmax, 507 
the rabbit papillary muscles were quickly stretched to 100% of Lmax with different groups 508 
of muscles being either control (n=11) or incubated with Rp-8-Br-PET-cGMPS [inhibitor 509 
of PKG, 10-6M, n=7], L-nitro-arginine [LNA, inhibitor of NO synthase, 10-5M, n=8], A-510 
71915 [natriuretic peptide receptor-A antagonist, 10-6M, n=7], hydroxocobalamin (HCB, 511 
NO scavenger, 10-3M, n=8) and LNA, HCB and A-71915 and combined (n=8). At the 512 
end of the experiment, the active portion of the muscle was quickly frozen in liquid 513 
nitrogen for posterior analysis. Additionally, in a second set of experiments, after 15 514 
minutes of stretch, muscles were again set to 92% Lmax over 15 minutes and subjected to 515 
another 15 minutes period of stretch to 100% of Lmax plus 92% Lmax over 15 minutes. 516 
 517 
Isolated skinned cardiomyocyte preparation: Force measurements were performed in 518 
single and mechanically isolated cardiomyocytes as previously described (Borbély et al., 519 
2005; Falcao-Pires et al., 2011) from rat hearts subjected to the perfusion protocol 520 
described above. PT was measured at SL ranging between 1.8µm to 2.3µm (0.1 µm step 521 
increases) at 15°C.  After PT stabilized at 2.2µm, cardiomyocytes were incubated for 40 522 
minutes at 20°C in relaxing solution containing either purified PKG1α, cGMP and 523 
dithiothreitol (n=25 and n=21 from stretch and control, respectively); or with protein 524 
phosphatase-1, and protein phosphatase lambda (n=25 and n=26 from stretch and control, 525 
respectively). After that, the same set of experiments was performed to measure PT at the 526 
same SL ranges. 527 
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Rat Transverse Aortic Constriction (TAC) banding model: A 3–0 non-absorbable silk 528 
suture was placed around the aortic arch of Wistar-Han rats (n=16) with 7 weeks of age, 529 
constricting it to the diameter of a 25G needle. Sham-treated animals (n=14), which 530 
underwent surgery with placement of a loose non-constrictive suture, were used as 531 
controls. After 21 weeks, echocardiographic images (VIVID 7 dimension system; 532 
General Electric-Vingmed Ultrasound) were obtained according to standards of 533 
American Society of Echocardiography (Lang et al., 2015) under anesthesia with 534 
ketamine and xylazine. Afterwards, a 1.4Fr microtip pressure-volume catheter (SPR-838, 535 
Millar Instruments) was inserted through an apical puncture wound into the LV cavity. 536 
The animal preparation was allowed to stabilize for 15 minutes, after which ventilation 537 
was suspended and a basal measurement performed at end-expiration. An acute volume 538 
load was the performed by intravenous administration of 15% of total blood volume of 539 
hydroxyethyl starch (Voluven®) during 5 minutes. New recordings were made after 540 
loading with suspension of the ventilation each 5 minutes until 15 minutes. At the end, 541 
the animal was euthanized by exsanguination, and samples were collected. 542 
 543 
Cardiac surgery patients: Hemodynamic evaluation was performed intraoperatively on 544 
patients with aortic stenosis and no evidence of LV hypertrophy on transthoracic 545 
echocardiogram (n=9) subjected to aortic valve replacement. After weaning 546 
cardiopulmonary bypass and in a hemodynamically stable period, pressure and volume 547 
were continuously measured by a 5-Fr combined catheter with 1 cm electrode spacing 548 
(SPC-551, Millar Instruments, Houston, TX) inserted through the ascending aorta. Once 549 
a basal acquisition was obtained, a volume overload was imposed through intravenous 550 
bolus of hydroxyethyl starch (Voluven®) and Trendelenburg positioning and values were 551 
registered at that moment and 15 minutes after. Four patients were male and five were 552 
female, ranging from 49 to 85 years old, and the surgery was performed by the same 553 
surgeon. 554 
 555 
Protein kinase activity: The phosphorylation of VASP, a myocardial PKG target, was 556 
measured using immunoblots; densitometry (over GAPDH expression) was performed 557 
and presented as previously described (van Heerebeek et al., 2012). 558 
 559 
Titin phosphorylation: After 1.8% SDS-PAGE, gels were stained with Pro-Q Diamond 560 
(phosphoprotein) for 1 hour and subsequently with Sypro Ruby (total protein) overnight. 561 
Phosphorylation signals on Pro-Q Diamond-stained gels were indexed to Sypro Ruby–562 
stained titin signals as previously described (Hamdani et al., 2013a). 563 
 564 
Statistical methods: Values are means ± SEM. Within the same group, the immediate 565 
effects of muscle stretch on the various experimental parameters were analysed with a 566 
paired Student’s t-test. Comparison of groups at discrete points (length, volume, time) 567 
was tested with unpaired Student’s t-test, being the time-dependent effects analysed by 568 
repeated measures two-way ANOVA. A p<0.05 was considered statistically significant. 569 
 570 
Results 571 
 572 
Effects of acute cardiac stretch in myocardial stiffness 573 
 574 
Plotting tension of acutely stretched papillary muscles from 92% to 100% Lmax over time 575 
clearly illustrates three phenomena (Fig. 4): (1) the Frank-Starling mechanism, with 576 
active tension increasing immediately upon stretch; (2) the slow force response, with 577 
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active tension further increasing sustainably over time; (3) the diastolic response, 578 
characterized by an immediate increase in PT, followed by a progressive and time-579 
dependent fall. Regarding this Stretch-Induced Compliance (SIC), acute stretch resulted 580 
in an immediate increase of PT from 1.5±0.3 to 6.3±1.2 mN.mm-2 in rabbit papillary 581 
muscles, from 3.0±0.5 to 8.1±1.2 mN.mm-2 in human atrial trabeculae, from 2.4±0.2 para 582 
8.2±0.6 mN.mm-2 in human ventricular strips. Subsequently, over the course of 15 583 
minutes, PT of rabbit papillary muscles decreased by 43±2% (Fig. 5B), human atrial 584 
trabeculae (n=14) by 27±8% and human ventricular strips (n=10) by 27±6% (Fig. 5C). 585 
Similarly, left ventricular diastolic pressure of isolated perfused rat hearts fell 43±2% 586 
after acute inflation of the LV balloon by 38±2 µL to increase diastolic pressure from 3 587 
to 10 mmHg (Fig. 5A). 588 
 589 
At the end of this time period, rabbit papillary muscles were returned to their original 590 
conditions by reducing length back to 92% Lmax. At this point, PT was significantly lower 591 
than that observed before stretch (0.8±0.2 mN.mm-2) but rose for the following 10 592 
minutes (1.1±0.3 mN.mm-2), becoming significantly higher than immediately after stretch 593 
but lower than before stretch (Fig. 6). The length-PT relationship in papillary muscles 594 
delineated by these “stretch” and “unstretch” interventions clearly illustrates the SIC and 595 
its partial persistence over the following 10 minutes (Fig. 7B) and analogous results are 596 
obtained in diastolic pressure-volume relationships of isolated rat hearts (Fig. 7A). 597 
 598 
To evaluate whether stress relaxation played a role in SIC, we stretched isolated skinned 599 
cardiomyocytes but no significant drop in PT was observed in this setting (Fig. 5D and 600 
Fig. 7C). Nonetheless, cardiomyocytes extracted from the LV free wall of five stretched 601 
isolated hearts presented with a markedly reduced PT at SL ranging from 1.8 to 2.3 µm 602 
compared to those extracted from other five hearts not submitted to the stretch protocol 603 
(Fig. 7D), confirming the adaptation occurs only in intact tissue at the myofillamental 604 
level. 605 
 606 
Lastly, in cardiac surgery patients evaluated in vivo, volume overload raised end-diastolic 607 
volume from 122.5±21.8 to 150.3±21.2 mL. Baseline end-diastolic pressure (EDP) was 608 
11.0±2.1 mmHg and, with overload, increased to 17.7±5.5 mmHg. After 15 minutes, EDP 609 
measured in cardiac cycles with the same end-diastolic volume of the previous situation, 610 
was clearly reduced, at 13.5±1.7 mmHg (Fig. 8). 611 
 612 
TAC banding compromises the decrease in stiffness in response to stretch 613 
 614 
Next, we used a model of cardiac hypertrophy and diastolic dysfunction, rats subjected 615 
to transverse aortic constriction (TAC) banding, to test SIC in a pathological context. 616 
Compared with sham-operated rats, TAC animals presented a significant increase in 617 
cardiac mass (63±16%) and echocardiographic studies revealed significantly higher left 618 
ventricular posterior wall dimension in systole and diastole. Furthermore, they presented 619 
a significant increase of LV EDP and time constant tau, indicating diastolic dysfunction. 620 
LV peak systolic pressure was also significantly higher when compared to Sham, but no 621 
significant change was detected in ejection fraction (Table 1). 622 
 623 
In response to acute myocardial stretch induced by volume overload, left ventricular EDP 624 
significantly increased in both groups (Sham +60±4%; TAC +79±37%). After 15 625 
minutes, EDP significantly decreased in Sham (15±1 vs. 9±1 mmHg), but not in TAC 626
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animals (19±4 vs. 16±3 mmHg), even if end-diastolic LV volume remained unchanged 627 
(Figure 9). 628 
 629 
PKG-mediated pathways in the response to acute myocardial stretch 630 
 631 
We hypothesized that PKG-mediated pathways were involved in priming myocardial 632 
stiffness to preload elevation. Because both NO and BNP are released upon myocardial 633 
stretch and increase cGMP levels, which activate PKG, we confirmed these observations 634 
by measuring PKG activity in the LV free wall of rats subjected to Langendorff perfusion. 635 
and found that myocardial stretch led to an increase in PKG activity (Fig. 10). 636 
 637 
To assess the individual contributions of these agents to the mechanism, we investigated 638 
whether blocking them would interfere with this effect. Incubation with LNA, HCB or 639 
A-71915 alone did not significantly alter the myocardial response to stretch and the 640 
muscles exhibited a similar behaviour to that observed under basal conditions. However, 641 
simultaneous incubation with all three drugs significantly blunted the decrease in PT after 642 
acute stretch (30±3 vs. 43±2%), as did the direct antagonism of PKG by Rp-8-Br-PET-643 
cGMPS (26±1 vs. 43±2%) (Figure 11). 644 
 645 
In order to functionally assess the contribution of phosphorylation of myofilamental 646 
elements to SIC, we incubated skinned cardiomyocytes extracted from stretched or 647 
control isolated rat hearts with protein phosphatases. After 40 minutes, we observed a 648 
significant upward dislocation of length-PT relationships in both groups, more prominent 649 
in the previously stretched group, approaching control levels (Fig. 12B). On the other 650 
hand, incubation of myocytes with PKG for 40 minutes reduced stiffness in the control 651 
group, as previously shown (Paulus et al., 1994; van Heerebeek et al., 2012; Hamdani et 652 
al., 2013a), but not in the stretched group (Fig. 12A). 653 
 654 
Titin phosphorylation in response to acute myocardial stretch 655 
 656 
Lastly, we compared total titin phosphorylation between groups of muscles subjected to 657 
acute stretch for 15 minutes and ones that were kept at constant length throughout the 658 
protocol. As illustrated in figure 13, a significant increase in the levels of phosphorylated 659 
titin was observed in rabbit papillary muscles (23±3 vs. 13±2%), as well as in human right 660 
atrial trabeculae (41±8 vs. 11±1%) and left ventricular strips (71±21 vs. 27±8%), 661 
suggesting this as a potential mechanism for the active modulation of myocardial stiffness 662 
following stretch. Interestingly, in the hearts from TAC rats not only was titin 663 
hypophosphorylated at baseline (73±6% of sham levels), but also the 51±12% increase in 664 
titin phosphorylation upon VO observed in sham was blunted to 30±14%. 665 
 666 
Discussion 667 
 668 
With this work, we intended to explore the response to hemodynamic overload in detail, 669 
well characterized from a contractile standpoint for decades, but of which a diastolic 670 
component had never been described. We observed that the latter, in the form of SIC, 671 
allows optimization of filling capacity at lower diastolic pressures and, therefore, 672 
potentiation of increased cardiac output triggered by acute myocardial stretch and 673 
prevention of pulmonary and systemic congestion. This mechanism augments mechanical 674 
distensibility in a potent and reproducible way in various mammalian models, being 675 
evolutionarily conserved up to the human species. Additionally, it is evident in 676 
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experimental preparations ranging from the isolated cardiomyocyte to in vivo 677 
hemodynamic analysis and including in vitro isolated intact hearts and muscle strips from 678 
ventricle and atrium. 679 
 680 
Acutely stretching healthy myocardium in vitro is followed by a drop in left ventricular 681 
EDP of intact hearts and PT of human and animal isolated muscle strips over time. After 682 
this period, EDP-volume and length-PT relationships, respectively, were shifted 683 
inferiorly, indicating decreased stiffness acquired after this stimulus. Furthermore, after 684 
its establishment, returning to baseline levels of preload reverses the effect incompletely, 685 
pointing to a role in both dynamic adaptation on the fly and more durable load 686 
conditioning.  687 
 688 
Decreased EDP is also seen after in vivo volume overload both in rats and in patients 689 
undergoing aortic valve replacement surgery. Although in this setting central neural 690 
reflexes and systemic humoral agents with myocardial effects likely contribute to the 691 
effect and cannot be distinguished from an intrinsic myocardial adaptation, its 692 
significance in this context still stands. 693 
 694 
Opposite to these situations, stretching isolated skinned cardiomyocytes does not evoke 695 
the same response per se. This suggests that the effect requires preserved subcellular 696 
compartmentalization to become manifest and, thus, depends on signaling pathways. 697 
Different stiffness is found only when comparing cardiomyocytes extracted from 698 
stretched and non-stretched hearts, i.e. when the intervention is performed on the intact 699 
organ. Taken together, these observations confirm that the effect is, to a grand extent, 700 
independent from the passive properties of cardiac extracellular matrix and that the 701 
effector players in these pathways must target myofillamentary elements. 702 
 703 
To translate these findings to a pathological context, we used a classic animal model of 704 
diastolic dysfunction induced by thoracic aortic constriction. Inducing in vivo acute 705 
hemodynamic overload in these animals revealed that, contrarily to sham individuals, 706 
EDP, already elevated at baseline, does not decline significantly over time. This 707 
difference is relevant, as inability to increase filling capacity in the face of a hemodynamic 708 
challenge can lead to congestion. Not only does this underline the importance of the 709 
diastolic component of the response to stretch, but also represents the first description 710 
that diastolic dysfunction is attributable to both increased myocardial stiffness and 711 
compromised modulation after acute load. 712 
 713 
We verified that PKG-related pathways were activated upon myocardial stretch and led 714 
to titin phosphorylation, representing the molecular basis explaining SIC and their 715 
dysregulation in the hypertrophied heart highlights their pathophysiological relevancy. In 716 
our study, the diastolic response to load is highly dependent on the activity of this enzyme, 717 
evident by the marked blunting of the effect observed upon its inhibition. 718 
 719 
A similar phenomenon was observed when NO production was inhibited, its intracellular 720 
stores were scavenged and the natriuretic peptide receptor A was inhibited, even though 721 
these interventions, by themselves, exerted no effect. This suggests a compensatory or 722 
redundant interaction between NO and BNP, both activating PKG through increase in 723 
intracellular cGMP concentration, although the subcellular compartment whereby this 724 
occurs may differ between the two mediators (Castro et al., 2006; Castro et al., 2010), as 725 
discussed above in the literature review. In spite of our establishment of the importance 726 
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of this pathway in SIC, future study is necessary to ascertain the most relevant NO 727 
synthase isoform and cellular cGMP pool in this context. 728 
 729 
At the sarcomeric level, our results corroborate previous studies showing that incubation 730 
of isolated cardiomyocytes with PKG increased their distensibility (Kruger et al., 2009; 731 
van Heerebeek et al., 2012; Hamdani et al., 2013a). Intriguingly, incubation of myocytes 732 
of previously stretched hearts, which already show decreased levels of PT, does not alter 733 
their stiffness profile. This points to a degree of saturation of kinase signalling, its target 734 
sites probably already phosphorylated by PKG concomitantly to its stretch-induced 735 
activation. On the flipside, incubation of cardiomyocytes with protein phosphatases 736 
shifted both groups’ length-PT curves upward and brought them very close to each other, 737 
thus uncovering the phosphorylation-dependent component of SIC. 738 
 739 
Some known targets of PKG include TNI (Layland et al., 2002), increasing cross bridge 740 
cycling, and PLB (Zhang et al., 2005), reducing its affinity for SERCA and boosting Ca2+ 741 
reuptake during diastole, but none of these actions link acute cardiac loading to decreased 742 
myocardial stiffness. We propose that this effect is in fact mediated by titin, 743 
phosphorylated by PKG on its N2B elastic element, increasing electric repulsion between 744 
its negatively charged amino acids and making it more distensible (Kruger et al., 2009; 745 
Kotter et al., 2013). 746 
 747 
Keeping up with this, higher titin phosphorylation levels were measured in stretched 748 
myocardial samples from human atria and ventricles and rabbit ventricles. In the latter 749 
case, samples analyzed after a period of “unstretch” reveal an incomplete reversal of 750 
phosphorylation levels, mirroring the persisting decrease in stiffness observed during the 751 
protocol. Furthermore, in vivo hemodynamic overload in rats induced titin 752 
phosphorylation in healthy animals but not in the diastolic dysfunction group, which 753 
presented baseline hypophosphorylation, confirming the central role of this mechanism 754 
in SIC and diastolic function. 755 
 756 
Our line of study may contribute to better understanding of mechanisms implicated in 757 
HFpEF-associated diastolic dysfunction. Firstly, it shows that the role of the cGMP/PKG 758 
pathway and titin phosphorylation in this context is not limited to modulation of 759 
ventricular stiffness but also encompasses the response to hemodynamic stress in 760 
different cardiac chambers. Since HFpEF is frequently characterized by exercise 761 
intolerance with fatigue, cough and dyspnea and underlying hypoactivity of the 762 
previously mentioned molecular mechanisms (Borlaug and Paulus, 2011; van Heerebeek 763 
et al., 2012), impaired SIC may be an additional pathophysiological link, leading to 764 
inability to optimize diastolic filling pressures after overload. Therefore, its potential 765 
diagnostic and therapeutic applications in this condition, which urgently needs new 766 
management options to reverse its tendency towards an unfavorable outcome, should be 767 
avidly studied. 768 
 769 
As such, the decline in EDP after acute load could be an early disease marker manifesting 770 
prior to symptom onset. Noninvasive indices of diastolic dysfunction such as the E/E’ 771 
ratio on transthoracic echocardiogram before, during and after preload increasing 772 
provocative maneuvers (e.g. exercise, limb elevation or Trendelenburg positioning) might 773 
be of diagnostic value. Poor adaptation to this stimulus could additionally be used as a 774 
disease classification criterion, which is not yet consensual (McMurray et al., 2012; 775 
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Yancy et al., 2013). Our group has begun recruitment of patients with unexplained 776 
shortness of breath for a pilot study of this technique for early detection of HFpEF. 777 
 778 
Lastly, restoring the molecular pathway represents a tempting pharmacological strategy 779 
and our results root in its favor. After the establishment of its significance in disease, it 780 
has been tested by the administration of sildenafil, a phosphodiesterase-5 inhibitor that 781 
abolishes myocardial cGMP hydrolysis (Takimoto et al., 2005; Bishu et al., 2011; 782 
Borlaug et al., 2015). Unfortunately, the large-scale randomized RELAX trial did not 783 
garner results supporting this treatment in HFpEF (Redfield et al., 2013) and, despite 784 
some flaws in its study design, it is likely that this intervention, by itself, does not suffice 785 
to alter clinical course. Indeed, waning action of upstream mediators may generate cGMP 786 
levels that, even with its breakdown inhibited, are inadequate to properly activate the 787 
pathway. Hence, riociguat, directly activating soluble guanylate cyclase (Bonderman et 788 
al., 2014), may reveal more effective. Moreover, other strategies might stem from 789 
targeted activation of other enzymes phosphorylating titin, such as PKA or 790 
Ca2+/calmodulin-dependent protein kinase (van Heerebeek et al., 2006; Hamdani et al., 791 
2013b). Finally, since our data point to a durable reduction in myocardial stiffness even 792 
after the original mechanical stimulus subsides, non-pharmacological interventions 793 
promoting cardiac stretch may be useful, including physical exercise. 794 
 795 
Conclusion 796 
 797 
Our study identifies a novel mechanism in cardiac physiology that bridges adaptation to 798 
loading into the realm of diastolic function. Through increased compliance, healthy hearts 799 
of various species, including humans, are able to accommodate load at lower pressures 800 
and further optimize cardiac output in this context. PKG-mediated pathways, culminating 801 
on titin phosphorylation, are essential to its development and time-dependent sustained 802 
effect. SIC is impaired in diastolic dysfunction, and this observation is a harbinger of its 803 
diagnostic and therapeutic implications.  804 
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Figures and Tables 
 
 
 
 
Figure 1: Acute cardiac overload. Schematic example of the normal intrinsic adaptation 
of the left ventricle to acute increase in preload. In this example, the additional modulation 
by autonomic nervous system is ignored, in order to highlight the intrinsic myocardial 
response to acute stretch. Myocardial stiffness changes in response to acute myocardial 
stretch have not yet been adequately evaluated. EDP: End Diastolic Pressure; VR: Venous 
Return; CO: Cardiac Output; AT: Active Tension; St: Myocardial Stiffness.  
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Figure 2: Myocardial mechanosensing. Acute myocardial stretch induces an increased 
myocardial tension that can be sensed by several potential mechanosensors. The 
connections between mechanosensors and activated signaling pathways are not yet fully 
understood. CN: calcineurin; ERK: extracellular signal-regulated kinase; FAK: focal 
adhesion kinase; PDE: phosphodiesterase; PKC: protein kinase C; SAC: stretch-activated 
channel.  
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Figure 3: Integrated signaling pathways. Diagram representing the molecular interplay 
between the various players in the acute response to stretch. The same mediators may 
exert different effects depending on the subcellular compartment. Question marks 
indicate yet unknown mechanisms. The proposed model is based on data obtained from 
different species and experimental models. Some signaling pathways may differ between 
species. ANG-II: angiotensin-II; CNH: cardiac natriuretic hormone; EGFR: epidermal 
growth factor receptor; ET: endothelin; ERK: extracellular signal-regulated kinase; 
HBEGF: heparin-binding epidermal growth factor; MMP: matrix metalloproteinase; 
NCX: sodium-calcium exchanger; NHE: sodium-proton exchanger; nNOS: neuronal NO 
synthase; PDE: phosphodiesterase; pGC-A: particulate guanylate cyclase A PK: protein 
kinase; PLB: phospholamban; PLC: phospholypase C ROS: reactive oxygen species; 
Ryr2: ryanodine receptor 2; sGC: soluble guanylate cyclase.  
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Figure 4. Effects of acute cardiac stretch in myocardial force and stiffness. After 
stretch of a cardiac muscle to a length in which develops maximal force (Lmax), active 
tension increases, firstly through the FSM and later by SFR. There is also a progressive 
and time-dependent decrease in PT.  
Cardiac response to acute stretch	
 29 
 
 
Figure 5. The variation of passive tension/diastolic pressure of rat heart (A), isolated 
papillary muscles from rabbit (B), human myocardial strips (C) and single skinned 
cardiomyocytes (D) over 15 minutes after acute myocardial stretch. In both isolated 
rat heart and isolated papillary muscles from rabbit right ventricle there is a decrease in 
PT over 15 minutes. The magnitude of the drops of the PT of papillary muscles and the 
end-diastolic pressure from rat hearts were quite similar, as well as the behaviour of the 
human myocardial strips between atria and ventricle. Stretching isolated skinned 
cardiomyocytes did not lead to the same response.  
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Figure 6. Effects of acute cardiac stretch and unstretch in rabbit right ventricle 
papillary muscles. After acute myocardial stretch, the unstretch to 92% Lmax led to a 
significantly decrease in passive tension at this length. A subsequent stretch led to a 
significantly lower passive tension increase regarding the first stretch as well to a lesser 
passive tension after 15 minutes of stretch.  
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Figure 7. Passive length-tension relationships before and after stretch (A-C), after 
unstretch. (A-B) and stretched versus control rat hearts (D). Relationships from rabbit 
papillary muscles (A), diastolic pressure-volume relationship in isolated rat hearts (B). 
Panel C and D refer to passive length-tension relationship in single skinned 
cardiomyocytes: C refers to before and after 15 minutes of stretch while D compares 
hearts previously or not stretched. * p< 0.05 vs. before stretch, and † p < 0.05 vs. Stretch.  
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Figure 8. End-diastolic pressure (EDP) in cardiac surgery patients before (basal), 
immediately after (Volume Overload) and 15 minute after (After 15 minutes) 
volume overload. There is a remarkable increase in EDP after volume overload, which 
returns closer to the baseline after 15 minutes. Pressures were measured in the last two 
situations identical values of EDP. * p<0.05. vs. volume overload. 
 
 
 
 
 
Figure 9. Hemodynamic response to the acute stretch induced by volume overload 
in sham (A) and TAC (B) rats. The acute myocardial stretch induced an increase in end-
diastolic pressure in both sham and TAC rats. After 15 minutes of stretch end-diastolic 
pressure significantly decreased only in sham group. * p < 0.05 vs. basal and # p < 0.05 
vs. 0min.  
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Figure 10. Enzymatic activity of PKG in myocardial tissue homogenates in control 
and stretched rat hearts. There is an increase in PKG activity in the hearts of rats 
subjected to 15 minutes of stretch. * p < 0.05 vs. control. 
 
 
 
 
 
 
 
Figure 11. PKG-mediated pathways in the response to acute myocardial stretch. 
Incubation with LNA, hydroxocobalamin or A-71915 alone did not significantly alter the 
myocardial response to stretch comparing to basal conditions. Simultaneous incubation 
with all three drugs significantly blunted the decrease in PT after acute stretch as did the 
direct antagonism of PKG by Rp-8-Br-PET-cGMPS. * p< 0.05 vs. basal.  
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Figure 12. Effect of phosphorylation (A) and dephosphorylation (B) in single 
skinned cardiomyocytes from stretch or control hearts. Only the cardiomyocytes 
extracted from control hearts had a significant downward shift in passive length-tension 
relationship over the entire range of SL after incubation with PKG (A). When 
cardiomyocytes were incubated with phosphatases the passive length-tension relationship 
of both groups shifted upward (B). * p< 0.05 vs. control, and † p < 0.05 vs. stretch. 
 
 
 
Figure 13. Titin phosphorylation levels in rabbit right ventricle papillary muscles 
(A), human myocardial muscles (atria and ventricle) (B) and sham and TAC 
banding rats (C).  The acute myocardial stretch over 15 minutes led to a significant 
increase of the titin phosphorylation levels, which were reverted after unstretch to 92% 
Lmax. Also in human myocardial stretch, titin phosphorylation levels increased after 
stretch. There is a blunt of the increase in titin phosphorylation levels in TAC banding 
rats in response to stretch. * p< 0.05 vs. control and † p < 0.05 vs. sham.  
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 Sham  TAC  
Body weight (g) 444±7 479±30 
Heart weight (g)  1.3±0.04 2.1±0.2* 
Echocardiographic data   
LVPWDd (mm) 1.5±0.2 1.9±0.1* 
LVPWDs (mm) 2.5±0.1 3.2±0.1* 
EF (%) 76±1 84±1 
E/E’ 9.9±0.8 16.8±1.7* 
IRT 18.0±0.5 22.0±1.0* 
Aortic gradient (mmHg) 2±13 61±5* 
Hemodynamic data   
LVEDP (mmHg) 5±1 12±2* 
LVPmax (mmHg) 123±5 156±9* 
Tau (ms) 11±0.3 21±4 
 
Table 1. Characteristics of sham operated (Sham) and aortic constriction (TAC) 
rats. LVPWDd, LVPWDs: Left ventricular posterior wall dimension in diastole and 
systole, respectively; LVDd: Left ventricular end diastolic diameter; EF: ejection 
fraction; IRT: Isovolumic relaxation time LVEDP: Left ventricular end diastolic pressure; 
LVPmax: peak systolic left ventricular pressure; Tau: time constant of isovolumic 
relaxation. * P<0.05 vs Sham. 
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